article thumbnail

U.S. Pharmaceutical Industry Seen to Focus on COVID-19 Treatments Amid Competitive Environment

ArchIntel

pharmaceutical industry in 2021 and beyond. The race to create new products against COVID-19 amid the emergence of new mutations is expected to eclipse every other effort in health care and pharmaceuticals this year. pharmaceutical and health care industry’s more notable CI executives. ArchIntelâ„¢ -.